05:31:51 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Prenumeration

Kalender

2025-02-27 Bokslutskommuniké 2024
2024-11-28 Kvartalsrapport 2024-Q3
2024-08-29 Kvartalsrapport 2024-Q2
2024-05-30 Kvartalsrapport 2024-Q1
2024-03-21 Ordinarie utdelning FLUO 0.00 DKK
2024-03-20 Årsstämma 2024
2024-02-28 Bokslutskommuniké 2023
2023-11-29 Kvartalsrapport 2023-Q3
2023-08-30 Kvartalsrapport 2023-Q2
2023-05-31 Kvartalsrapport 2023-Q1
2023-03-22 Ordinarie utdelning FLUO 0.00 DKK
2023-03-21 Årsstämma 2023
2023-02-28 Bokslutskommuniké 2022
2022-11-24 Kvartalsrapport 2022-Q3
2022-08-25 Kvartalsrapport 2022-Q2
2022-05-31 Kvartalsrapport 2022-Q1
2022-05-19 Ordinarie utdelning FLUO 0.00 DKK
2022-05-18 Årsstämma 2022
2022-03-30 Bokslutskommuniké 2021
2021-11-24 Kvartalsrapport 2021-Q3
2021-08-25 Kvartalsrapport 2021-Q2
2021-05-26 Kvartalsrapport 2021-Q1
2021-05-03 Ordinarie utdelning FLUO 0.00 DKK
2021-02-26 Bokslutskommuniké 2020
2021-02-09 Årsstämma 2021
2020-11-20 Kvartalsrapport 2020-Q3
2020-08-14 Kvartalsrapport 2020-Q2
2020-05-27 Kvartalsrapport 2020-Q1
2020-04-09 Ordinarie utdelning FLUO 0.00 DKK
2020-04-08 Årsstämma 2020
2020-02-28 Bokslutskommuniké 2019
2019-11-29 Kvartalsrapport 2019-Q3
2019-05-31 Kvartalsrapport 2019-Q1

Beskrivning

LandDanmark
ListaFirst North Stockholm
SektorHälsovård
IndustriMedicinteknik
FluoGuide är ett danskt bolag verksamma inom medicinteknik. Bolaget affärsfokus återfinns inom forskning och utveckling av behandlingar mot olika cancerformer, med störst fokus på utveckling av produkter som vägleder vid kirurgiska ingrepp. Produkterna binder till sig cancercellerna som då lyser upp och är avsedda att användas för att med precision kunna ta bort skadliga tumörer i patientens vävnad.
2021-09-14 11:54:49
Copenhagen, Denmark, 14 September 2021 – FluoGuide A/S (“FluoGuide” or the “Company”) today announces that Morten Albrechtsen (CEO), Andreas Kjær (CSO), Henrik Moltke (CFO), Mats Thoren (board member) and Micaela Sjøkvist (board member) have purchased shares. Shomit Ghose (board member) has sold shares to pay income tax on his shareholdings in FluoGuide due to U.S. tax regulations.
FluoGuide A/S
Overview of share transactions September 14, 2021, of members of the Board and Managment
Number of shares Average Share price***) Shareholding after purchase Votes and capital %
Member of Board and Management that has bougth shares
 Micaela Sjökvist, Board member                             741 109.71                                            62,163 0.55%
 Mats Thorén, Board member                             741 109.71                                                 741 0.01%
 Henrik Moltke, CFO                          1,216 109.71                                              1,216 0.01%
 Life Science IVS*)                          1,216 109.71                                       2,126,107 18.78%
 Wexotec ApS **)                          1,216 109.71                                       1,488,610 13.15%
Member of Board that has sold shares Number of shares Average Share price***) Shareholding after sale Votes and capital %
Shomit Ghose                         4,167 104.82                                            35,643 0.31%
*) Owned by Andreas Kjær, CSO, Board member
**) Owned by Morten Alberchtsen, CEO
***) Trade between 30 August and 13 September 2021

“Due to the success of FluoGuide, I have to pay tax on my shareholdings of FluoGuide and I have decided to finance this by selling some of my shares in FluoGuide”, says Shomit Ghose, member of the Board of Directors of FluoGuide and continues: “I have a strong confidence in FluoGuide with a visionary leadership, promising technology and execution power I have rarely seen even compared to a U.S. standard. I am very proud to be part of its exciting development and committed to contribute to fully utilizing FluoGuide’s data utilization potential in advance surgical guidance.”

The transactions are reported to The Danish Financial Supervisory Authority (Danish: "Finanstilsynet") in accordance with current regulations.


This disclosure contains information that Fluoguide is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 14-09-2021 11:55 CET.